Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
In a 6-month carcinogenicity study in rasH2 transgenic mice, tirzepatide at doses of 1, 3, and 10 mg/kg administered by subcutaneous injection twice weekly was not tumorigenic
Individuals must ensure they are eating foods containing B12 to prevent developing a B12 deficiency
The injection must be given by a healthcare professional
Clinical studies have shown Tesofensine can result in up to 10% body weight reduction, which is greater than many traditional weight loss medications
US$ 24.08
US$ 23.51
US$ 20.99
US$ 28.68
US$ 26.89
